Financials

  • Market Capitalization 83.1 M
  • Employee 162
  • Founded 2015
  • CEO N/A
  • Website www.gossamerbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00MVWLLM2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.13
Price to sales ratio
14.62

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4019
MAIA
MAIA Biotechnology, Inc. Common Stock
1.39 USD-1.42%0.00%+11.20%-33.17%84.55 M USD
4021
ACET
Adicet Bio, Inc. - Common Stock
9.01 USD+0.67%-4.35%+8.82%+1070.13%84.35 M USD
4037
TENX
Tenax Therapeutics, Inc. - Common Stock
2.19 USD+3.30%+21.67%-86.14%-70.99%81.96 M USD
4039
TELO
Telomir Pharmaceuticals, Inc. - Common Stock
1.19 USD+1.71%+5.31%0.00%-16.20%81.84 M USD

Frequently asked questions about Gossamer Bio, Inc. Common Stock

What is the Gossamer Bio, Inc. Common Stock stock price today?

The current price of Gossamer Bio, Inc. Common Stock (GOSS) is 0.17. Over the past 24 hours, the stock has changed by 0.00%. Follow the GOSS chart for real-time price dynamics.

What is the stock ticker of Gossamer Bio, Inc. Common Stock?

Gossamer Bio, Inc. Common Stock trades under the ticker GOSS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Gossamer Bio, Inc. Common Stock stock going up?

GOSS has changed by 0.00% over the last week, -19.05% over the last month, and -92.95% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Gossamer Bio, Inc. Common Stock?

Gossamer Bio, Inc. Common Stock currently has a market capitalization of 83.1 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Gossamer Bio, Inc. Common Stock earnings last quarter?

Last quarter, Gossamer Bio, Inc. Common Stock reported earnings of 0.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Gossamer Bio, Inc. Common Stock revenue for the last quarter?

Gossamer Bio, Inc. Common Stock reported quarterly revenue of 9.24 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Gossamer Bio, Inc. Common Stock net income for the last quarter?

Gossamer Bio, Inc. Common Stock reported net income of 16.9 M for the last quarter. The previous quarter showed -46.66 M, which means net income changed by +136.22%.

How many employees does Gossamer Bio, Inc. Common Stock have?

As of the latest available data, Gossamer Bio, Inc. Common Stock has 162 employees. Workforce size can provide additional context about the company's scale and operations.

What is Gossamer Bio, Inc. Common Stock EBITDA?

Gossamer Bio, Inc. Common Stock EBITDA is -21.51 M, and its EBITDA margin is -232.85%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Gossamer Bio, Inc. Common Stock stock?

You can buy Gossamer Bio, Inc. Common Stock (GOSS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Gossamer Bio, Inc. Common Stock stock?

Investing in Gossamer Bio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GOSS chart and related analysis on metatrader.com as part of your research.

News